Your browser doesn't support javascript.
loading
Reimbursement and pricing of regenerative medicine in South Korea: key factors for achieving reimbursement.
Cho, Eun; Yoo, Seung-Lai; Kang, Youngju; Lee, Jong Hyuk.
Afiliação
  • Cho E; College of Pharmacy, Sookmyung Women's University, Seoul 04310, Republic of Korea.
  • Yoo SL; Department of Insurance Benefits, National Health Insurance, Wonju 26464, Republic of Korea.
  • Kang Y; College of Pharmacy, Yonsei University, Seoul 03722, Republic of Korea.
  • Lee JH; Department of Pharmaceutical engineering, College of Life & Health Sciences, Hoseo University, Asan 31499, Republic of Korea.
Regen Med ; 15(4): 1550-1560, 2020 04.
Article em En | MEDLINE | ID: mdl-32356480
In the South Korean health technology assessment system, prices of alternative medicines, incremental cost-effectiveness ratios in pharmaco-economic evaluations and patient access improvement systems such as risk-sharing agreements are the most important factors concerning the reimbursement of regenerative medicine (RM). Research and development companies in RM should review the key features of these medicines throughout the product development cycle to increase the probability of successful reimbursement. In addition, the South Korean government should take steps to improve the system to reflect the unique characteristics and value of RM in the reimbursement and pricing policy, to revitalize research and development, and increase patient access.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Medicina Regenerativa / Política de Saúde / Reembolso de Seguro de Saúde Tipo de estudo: Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Regen Med Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Medicina Regenerativa / Política de Saúde / Reembolso de Seguro de Saúde Tipo de estudo: Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Regen Med Ano de publicação: 2020 Tipo de documento: Article